You are here

  • Home
  • Archive
  • Volume 25, Issue 8
  • Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer

Article info

Article menu
Download PDFPDF
Cervical Cancer
Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer

Authors

  1. Address correspondence and reprint requests to Evis Sala, MD, PhD, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065. E-mail: salae@mskcc.org.

Citation

Sala E, Micco M, Burger IA, et al
Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer
International Journal of Gynecologic Cancer 2015;25:1461-1467.

Publication history

  • Received October 30, 2014
  • First published October 1, 2015.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2015 by IGCS and ESGO